Heart Transplant Specialists are experts in managing patients with advanced heart failure who require heart transplantation as a life-saving intervention. Their work begins with comprehensive assessments to determine transplant eligibility, evaluating not only cardiac function but also overall health status and psychosocial factors. These specialists coordinate every stage of the transplant process, including donor matching, surgical transplantation, and immediate postoperative care. They employ sophisticated immunosuppressive regimens to prevent organ rejection and closely monitor patients for complications such as infections or graft dysfunction.
Collaborating within multidisciplinary teams, heart transplant specialists work alongside surgeons, cardiologists, nurses, and social workers to provide holistic care throughout the patient’s transplant journey. They also engage in research aimed at improving long-term outcomes, developing new therapies to minimize rejection, and enhancing patient quality of life. Their role extends beyond surgery, encompassing lifelong follow-up to manage medications and address comorbidities. By advancing transplantation science and patient care, these specialists give hope to those with end-stage heart disease, improving survival rates and setting new standards in cardiac medicine. Their dedication to innovation and patient-centered care continues to shape the future of heart transplantation worldwide. They are also pivotal in educating patients and families about the complexities of transplantation and post-operative lifestyle adjustments.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India